Estimated delivery in United States, on Monday 10 Feb 2025
Product Information
Name:
Dehydro Monocrotaline, 90%
Controlled Product
Synonyms:
- (3R,4R,5R,13aR)-4,5,8,12,13,13a-Hexahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione
- Monocrotaline Pyrrole, 3,8-Didehydromonocrotaline
- 2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,12,13,13a-hexahydro-4,5-dihydroxy-3,4,5-trimethyl-, (3R,4R,5R,13aR)-
- Monocrotaline, 3,8-didehydro-
- 2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,12,13,13a-hexahydro-4,5-dihydroxy-3,4,5-trimethyl-, [3R-(3R*,4R*,5R*,13aR*)]-
- 20-Norcrotalanan-11,15-dione, 3,8-didehydro-14,19-dihydro-12,13-dihydroxy-, (13α,14α)-
Description:
Stability Light, Moisture and Temperature Sensitive
Applications A metabolite of the potent hepatotoxin Monocrotaline.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Mattocks, A.R.: J.C.S., 8, 1155 (1969), Tepe, J.J. and Williams, R.M.: JACS, 121, 13, 2951 (1999)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
323.34
Formula:
C16H21NO6
Purity:
90%
Color/Form:
Neat
InChI:
InChI=1S/C16H21NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,6,9,11,20-21H,5,7-8H2,1-3H3/t9-,11+,15+,16-/m0/s1
InChI key:
InChIKey=ZONSVLURFASOJK-BMBOXURJSA-N
SMILES:
C[C@H]1C(=O)O[C@H]2CCn3ccc(c32)COC(=O)C(C)(O)C1(C)O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-D229750 Dehydro Monocrotaline, 90%
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
